Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celogen is a diversified pharmaceutical and biotechnology company headquartered in Navi Mumbai, India, specializing in the development, manufacturing, and global export of a wide range of healthcare products. The company operates through two primary divisions: Celogen Pharma, which focuses on high-quality pharmaceutical formulations and generics, and Celogen Biologics, which is dedicated to advanced biotherapeutics and biosimilars. A significant milestone for the company is its collaboration with the Indian Institute of Technology Bombay (IITB) to develop indigenous CAR-T cell therapies for hematological malignancies. Celogen maintains a strong international presence, exporting products to over 30 countries across Africa, Southeast Asia, and Latin America. By balancing its core generics business with high-value innovative research in cell therapy and biosimilars, Celogen positions itself as a key player in the evolving Indian biotech landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celogen.